rs17429833
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021101.5(CLDN1):c.-13G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0797 in 1,612,174 control chromosomes in the GnomAD database, including 5,555 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.066 ( 385 hom., cov: 33)
Exomes 𝑓: 0.081 ( 5170 hom. )
Consequence
CLDN1
NM_021101.5 5_prime_UTR
NM_021101.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.154
Genes affected
CLDN1 (HGNC:2032): (claudin 1) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. Loss of function mutations result in neonatal ichthyosis-sclerosing cholangitis syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 3-190322219-C-G is Benign according to our data. Variant chr3-190322219-C-G is described in ClinVar as [Benign]. Clinvar id is 261401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0849 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN1 | NM_021101.5 | c.-13G>C | 5_prime_UTR_variant | 1/4 | ENST00000295522.4 | NP_066924.1 | ||
CLDN16 | NM_001378492.1 | c.-279+7160C>G | intron_variant | NP_001365421.1 | ||||
CLDN16 | NM_001378493.1 | c.-279+31628C>G | intron_variant | NP_001365422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN1 | ENST00000295522.4 | c.-13G>C | 5_prime_UTR_variant | 1/4 | 1 | NM_021101.5 | ENSP00000295522 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0659 AC: 10033AN: 152194Hom.: 386 Cov.: 33
GnomAD3 genomes
AF:
AC:
10033
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0666 AC: 16468AN: 247120Hom.: 664 AF XY: 0.0685 AC XY: 9192AN XY: 134224
GnomAD3 exomes
AF:
AC:
16468
AN:
247120
Hom.:
AF XY:
AC XY:
9192
AN XY:
134224
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0811 AC: 118419AN: 1459862Hom.: 5170 Cov.: 31 AF XY: 0.0804 AC XY: 58384AN XY: 726270
GnomAD4 exome
AF:
AC:
118419
AN:
1459862
Hom.:
Cov.:
31
AF XY:
AC XY:
58384
AN XY:
726270
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0659 AC: 10031AN: 152312Hom.: 385 Cov.: 33 AF XY: 0.0648 AC XY: 4827AN XY: 74466
GnomAD4 genome
AF:
AC:
10031
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
4827
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
171
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 10, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at